scPharmaceuticals Inc. (SCPH) earnings
SCPH earnings moved a median of -0.69% by the close. Quarterly and annual SCPH reports and results, each read against the price at its own news timestamp. Back to the SCPH overview →
21 measured SCPH earnings events.
Where these SCPH earnings landedvs 21 measured SCPH earnings reactions
| Middle 50% of SCPH earnings reactions | -3.29% to +5.06% |
|---|---|
| Median reaction (to close) | -0.69% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 SCPH earnings events with a measured close landed between -3.29% and +5.06%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q scPharmaceuticals Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.10% | -2.94% | |
| scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -2.10% | -2.94% | |
| scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025 | Press release | +0.03% | +3.19% | |
| Form 10-Q scPharmaceuticals Inc. For: Mar 31 | SEC filing · Form 10-Q | +22.50% | +30.91% | |
| scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +22.50% | +30.91% | |
| scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 | Press release | +0.00% | +4.15% | |
| Form 10-K scPharmaceuticals Inc. For: Dec 31 | SEC filing · Form 10-K | +5.54% | +1.01% | |
| Form 10-Q/A scPharmaceuticals Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.28% | +0.28% | |
| Form 10-Q scPharmaceuticals Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.79% | -4.00% | |
| scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | -0.79% | -4.00% | |
| scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 | Press release | +1.15% | -0.69% | |
| Form 10-Q scPharmaceuticals Inc. For: Jun 30 | SEC filing · Form 10-Q | +5.39% | +5.64% | |
| scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +5.39% | +5.64% | |
| scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 | Press release | +0.00% | -6.28% | |
| Form 10-Q scPharmaceuticals Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.76% | +5.06% | |
| scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +2.76% | +5.06% | |
| scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024 | Press release | +0.00% | -2.90% | |
| Form 10-K scPharmaceuticals Inc. For: Dec 31 | SEC filing · Form 10-K | -1.80% | -4.33% | |
| Form 10-Q scPharmaceuticals Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -3.29% | |
| scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +0.00% | -3.29% | |
| scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 | Press release | +0.56% | -5.98% |
Keep exploring
More SCPH: analyst actions → · SEC filings → · SCPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | 180 | 0.00% | 48% |
| BIO BLAST PHARMA LTD ORDINARY (ORPN) | 180 | 0.00% | 35% |
| vTv Therapeutics Inc. - Class A (VTVT) | 180 | 0.00% | 39% |
| SOL GLOBAL INVTS CORP (SOLCF) | 179 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.